Document Detail

Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
MedLine Citation:
PMID:  20956487     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Myeloperoxidase (MPO) is a leucocyte enzyme that catalyses the formation of a number of reactive oxidant species.
OBJECTIVE: The purpose of this study is to evaluate the relationship between angiographic coronary plaque morphology in patients with unstable angina pectoris (UAP) or stable angina pectoris (SAP) and MPO levels.
PATIENTS AND DESIGN: Plasma MPO levels on admission were measured in 236 patients with UAP, 146 with SAP and 85 control subjects using an ELISA kit. The angiographic morphology of the culprit lesion was classified into two types, simple or complex, based on the Ambrose classification. In addition, 61 atherectomy specimens obtained from a different cohort of patients with UAP and SAP were studied immunohistochemically for MPO.
RESULTS: Median (IQR) plasma MPO levels in patients with UAP with a complex lesion were significantly higher than in patients with a simple lesion (41.9 (21.7–73.7) ng/ml vs 20.5 (15.9–27.9) ng/ml, p<0.0001), but there was no significant difference between the two groups in patients with SAP. On multivariate analysis, raised plasma MPO levels and Braunwald class III were independent factors for angiographically-detected complex lesions (adjusted OR 12.49, 95% CI 3.24 to 48.17, p=0.0002). In the atherectomy specimens the number of MPO-positive cells in patients with UAP with complex lesions was significantly higher (p<0.0005) than in patients with simple lesions. Moreover, in this cohort, plasma MPO levels were positively correlated with the number of MPO-positive cells in atherectomy specimens (R=0.42, p=0.024).
CONCLUSIONS: This study shows that increased expression and plasma MPO levels are closely related to the presence of angiographically-detected complex lesion morphology in patients with UAP.
T Naruko; A Furukawa; K Yunoki; R Komatsu; M Nakagawa; Y Matsumura; N Shirai; K Sugioka; M Takagi; T Hozumi; A Itoh; K Haze; M Yoshiyama; A E Becker; M Ueda
Related Documents :
4036817 - Effect of ventricular fibrillation complicating acute myocardial infarction on long-ter...
11698937 - Risk factors of ischaemic heart disease and long-term outcome after coronary bypass sur...
1554127 - Preoperative cardiac evaluation for noncardiac surgery: a functional approach.
23312907 - Comparison of electrocardiogram avr qrs metrics, as indices of the sums of leads i and ...
23706007 - Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: ...
24325727 - Ultrasound presentation of abdominal tuberculosis in a german tertiary care center.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  96     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-19     Completed Date:  2010-11-08     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  1716-22     Citation Subset:  AIM; IM    
Department of Cardiology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka 534-0021, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina Pectoris / enzymology,  radiography,  surgery
Angina, Unstable / enzymology*,  radiography,  surgery
Atherectomy, Coronary
Biological Markers / blood,  metabolism
Cohort Studies
Coronary Angiography
Middle Aged
Peroxidase / blood,  metabolism*
Reg. No./Substance:
0/Biological Markers; EC
Erratum In:
Heart. 2010 Dec;96(24):2044-5

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
Next Document:  Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological v...